FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1969798938> ?p ?o ?g. }

• W1969798938 endingPage "331" @default.
• W1969798938 startingPage "322" @default.
• W1969798938 abstract "Earlier studies have demonstrated that the agonists of the mGlu(2/3) receptors produced anxiolytic actions after peripheral administration. However, the mechanism of their action is still not clear. Therefore the aim of the present study was to specify the role of the GABAergic and serotonergic system in the mechanism of the anxiolytic activity of group II mGlu receptor activators by using the stress induced hyperthermia test (SIH) in singly housed mice. We used an orthosteric mGlu(2/3) receptor agonist, LY379268, which induced anti-hyperthermic efficacy in the doses of 1-5mg/kg (73% of inhibition after a highest dose). The effect of the second ligand used, a mGlu(2) receptor positive modulator (PAM), LY487379, was observed in a dose range of 0.5-5mg/kg and reached 53% of the inhibition. The blockade of GABAergic system by GABA(A) receptor antagonist flumazenil (10mg/kg) or GABA(B) receptor antagonist CGP55845 (10mg/kg), and the blockade of serotonergic system by 5-HT(1A) receptor antagonist WAY100635 (0.1 and 1mg/kg) or 5-HT(2A/2C) receptor antagonist ritanserin (0.5mg/kg) had no influence on the anti-hyperthermic effect induced by effective dose of LY379268. However, the action of the effective dose of LY487379 was enhanced when co-administered with flumazenil, WAY100635 (0.1mg/kg) and ritanserin. Similar results were observed for the subeffective dose of LY379268 (0.5mg/kg). WAY100635 in a dose of 1mg/kg did not induce any enhancing effect on the activity of compounds. Therefore, it seems that the antagonism towards GABA(A) receptors, presynaptic 5-HT(1A) and postsynaptic 5-HT(2A/2C) receptors is responsible for the phenomenon. This article is part of a Special Issue entitled 'Anxiety and Depression'." @default.
• W1969798938 created "2016-06-24" @default.
• W1969798938 creator A5017334559 @default.
• W1969798938 creator A5040355648 @default.
• W1969798938 creator A5052898318 @default.
• W1969798938 creator A5082517862 @default.
• W1969798938 creator A5090499212 @default.
• W1969798938 date "2012-01-01" @default.
• W1969798938 modified "2023-10-17" @default.
• W1969798938 title "On the mechanism of anti-hyperthermic effects of LY379268 and LY487379, group II mGlu receptors activators, in the stress-induced hyperthermia in singly housed mice" @default.
• W1969798938 cites W1487123995 @default.
• W1969798938 cites W1549849604 @default.
• W1969798938 cites W1558293110 @default.
• W1969798938 cites W1963690073 @default.
• W1969798938 cites W1970034042 @default.
• W1969798938 cites W1970596941 @default.
• W1969798938 cites W1972722155 @default.
• W1969798938 cites W1976370881 @default.
• W1969798938 cites W1978013466 @default.
• W1969798938 cites W1979981960 @default.
• W1969798938 cites W1990246915 @default.
• W1969798938 cites W1998088135 @default.
• W1969798938 cites W2001311316 @default.
• W1969798938 cites W2008282906 @default.
• W1969798938 cites W2009617328 @default.
• W1969798938 cites W2010734130 @default.
• W1969798938 cites W2015604992 @default.
• W1969798938 cites W2017355539 @default.
• W1969798938 cites W2024942419 @default.
• W1969798938 cites W2029007040 @default.
• W1969798938 cites W2030835675 @default.
• W1969798938 cites W2031409382 @default.
• W1969798938 cites W2035331909 @default.
• W1969798938 cites W2043166209 @default.
• W1969798938 cites W2044866903 @default.
• W1969798938 cites W2045861729 @default.
• W1969798938 cites W2049001896 @default.
• W1969798938 cites W2059015502 @default.
• W1969798938 cites W2061070984 @default.
• W1969798938 cites W2066051567 @default.
• W1969798938 cites W2070290419 @default.
• W1969798938 cites W2074056751 @default.
• W1969798938 cites W2074744435 @default.
• W1969798938 cites W2076802266 @default.
• W1969798938 cites W2076974408 @default.
• W1969798938 cites W2079876678 @default.
• W1969798938 cites W2082369948 @default.
• W1969798938 cites W2085477113 @default.
• W1969798938 cites W2085673544 @default.
• W1969798938 cites W2089020041 @default.
• W1969798938 cites W2102666165 @default.
• W1969798938 cites W2102974182 @default.
• W1969798938 cites W2103292884 @default.
• W1969798938 cites W2106042714 @default.
• W1969798938 cites W2116896173 @default.
• W1969798938 cites W2123250581 @default.
• W1969798938 cites W2124768361 @default.
• W1969798938 cites W2137452068 @default.
• W1969798938 cites W2138726764 @default.
• W1969798938 cites W2150026124 @default.
• W1969798938 cites W2150079584 @default.
• W1969798938 cites W2152027982 @default.
• W1969798938 cites W2152463107 @default.
• W1969798938 cites W2156600215 @default.
• W1969798938 cites W2166903177 @default.
• W1969798938 doi "https://doi.org/10.1016/j.neuropharm.2011.07.042" @default.
• W1969798938 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21855555" @default.
• W1969798938 hasPublicationYear "2012" @default.
• W1969798938 type Work @default.
• W1969798938 sameAs 1969798938 @default.
• W1969798938 citedByCount "20" @default.
• W1969798938 countsByYear W19697989382012 @default.
• W1969798938 countsByYear W19697989382013 @default.
• W1969798938 countsByYear W19697989382014 @default.
• W1969798938 countsByYear W19697989382015 @default.
• W1969798938 countsByYear W19697989382016 @default.
• W1969798938 countsByYear W19697989382018 @default.
• W1969798938 countsByYear W19697989382020 @default.
• W1969798938 countsByYear W19697989382021 @default.
• W1969798938 countsByYear W19697989382022 @default.
• W1969798938 crossrefType "journal-article" @default.
• W1969798938 hasAuthorship W1969798938A5017334559 @default.
• W1969798938 hasAuthorship W1969798938A5040355648 @default.
• W1969798938 hasAuthorship W1969798938A5052898318 @default.
• W1969798938 hasAuthorship W1969798938A5082517862 @default.
• W1969798938 hasAuthorship W1969798938A5090499212 @default.
• W1969798938 hasConcept C170493617 @default.
• W1969798938 hasConcept C185592680 @default.
• W1969798938 hasConcept C26702167 @default.
• W1969798938 hasConcept C2775864247 @default.
• W1969798938 hasConcept C2776885963 @default.
• W1969798938 hasConcept C2777450907 @default.
• W1969798938 hasConcept C2778122271 @default.
• W1969798938 hasConcept C2778409475 @default.
• W1969798938 hasConcept C2778938600 @default.
• W1969798938 hasConcept C37000724 @default.
• W1969798938 hasConcept C55493867 @default.
• W1969798938 hasConcept C58732023 @default.

• next